IDEXX Laboratories Inc (IX1) – Cena in novice

Simboli Simboli	Cena	Sprememba	Odstotna sprememba	Trend	Prejšnja končna cena	Odpri	Visoka	Nizka	Promet	Tržna kapitalizacija
SIXB Materials SIXB Materials	SIXB −0,32%	1.100,57	−3,53	−0,32%	—	1.104,10	1.103,92	1.108,75	1.097,16	—	—
SIXC Communications SIXC Communications	SIXC +0,16%	605,15	+0,99	+0,16%	—	604,16	604,16	610,19	604,12	—	—
SIXE Energy SIXE Energy	SIXE −0,22%	1.195,19	−2,62	−0,22%	—	1.197,81	1.200,58	1.213,07	1.192,02	—	—
SIXI Industrials SIXI Industrials	SIXI −0,03%	1.739,91	−0,50	−0,03%	—	1.740,41	1.739,55	1.750,27	1.730,60	—	—
SIXM Financials SIXM Financials	SIXM +0,65%	638,56	+4,12	+0,65%	—	634,44	633,13	639,87	633,01	—	—
SIXR Staples SIXR Staples	SIXR −1,11%	831,57	−9,33	−1,11%	—	840,90	839,53	841,73	831,10	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,82%	213,36	−1,77	−0,82%	—	215,13	215,13	215,85	213,24	—	—
SIXT Technology SIXT Technology	SIXT +0,17%	3.234,18	+5,47	+0,17%	—	3.228,71	3.225,62	3.235,43	3.198,95	—	—
SIXU Utilities SIXU Utilities	SIXU −0,02%	935,65	−0,22	−0,02%	—	935,87	938,37	942,00	935,65	—	—
SIXV Health care SIXV Health care	SIXV −0,54%	1.449,26	−7,86	−0,54%	—	1.457,12	1.452,74	1.466,88	1.449,18	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,72%	2.382,45	−17,39	−0,72%	—	2.399,84	2.389,71	2.394,61	2.371,22	—	—

Simboli

Cena

Sprememba

Odstotna sprememba

Trend

Prejšnja končna cena

Odpri

Visoka

Nizka

Promet

Tržna kapitalizacija

SIXB

Materials

SIXB

Materials

SIXB

−0,32%

1.100,57

−3,53

−0,32%

—

1.104,10

1.103,92

1.108,75

1.097,16

—

SIXC

Communications

SIXC

Communications

SIXC

+0,16%

605,15

+0,99

+0,16%

—

604,16

610,19

604,12

—

SIXE

Energy

SIXE

Energy

SIXE

−0,22%

1.195,19

−2,62

−0,22%

—

1.197,81

1.200,58

1.213,07

1.192,02

—

SIXI

Industrials

SIXI

Industrials

SIXI

−0,03%

1.739,91

−0,50

−0,03%

—

1.740,41

1.739,55

1.750,27

1.730,60

—

SIXM

Financials

SIXM

Financials

SIXM

+0,65%

638,56

+4,12

+0,65%

—

634,44

633,13

639,87

633,01

—

SIXR

Staples

SIXR

Staples

SIXR

−1,11%

831,57

−9,33

−1,11%

—

840,90

839,53

841,73

831,10

—

SIXRE

Real estate

SIXRE

Real estate

SIXRE

−0,82%

213,36

−1,77

−0,82%

—

215,13

215,85

213,24

—

SIXT

Technology

SIXT

Technology

SIXT

+0,17%

3.234,18

+5,47

+0,17%

—

3.228,71

3.225,62

3.235,43

3.198,95

—

SIXU

Utilities

SIXU

Utilities

SIXU

−0,02%

935,65

−0,22

−0,02%

—

935,87

938,37

942,00

935,65

—

SIXV

Health care

SIXV

Health care

SIXV

−0,54%

1.449,26

−7,86

−0,54%

—

1.457,12

1.452,74

1.466,88

1.449,18

—

SIXY

Discretionary

SIXY

Discretionary

SIXY

−0,72%

2.382,45

−17,39

−0,72%

—

2.399,84

2.389,71

2.394,61

2.371,22

—

IX1:ETR

IDEXX Laboratories Inc

500,80 €

+2,29%

(+11,20) 1D

17. apr., 17:35:46 GMT +2 · EUR

Vsi simboli

TLDD

MAKS

	Simbol	Cena	Sprememba	Odstotna sprememba

Podobna sredstva

J5A

Warner Bros. Discovery

Init Innovation In Traffic Systems SE

44,70 €

−2,19%

Novice

Iz virov v spletu

MarketBeat

pred 2 dnevoma

Montrusco Bolton Investments Inc. Decreases Stock Position in IDEXX Laboratories, Inc. $IDXX

Profil

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia

Vsebina z UI lahko vsebuje napake. Več o tem

PomočPošljite povratne informacijeZasebnost Pogoji Zavrnitev odgovornosti

Finance

Raziskovanje